Melissa B. Epperly - 03 Jul 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role: Director
Issuer symbol: ROIV
Report date: 03 Jul 2023
Net transaction value: $0
Form type: 4
Accepted by SEC: 06 Jul 2023, 21:30:23 UTC
Previous filing: 16 Jun 2023
Next filing: 14 Sep 2023
SEC filing: View on sec.gov
Reporting owner signature: By: /s/ Jo Chen, as Attorney-in-Fact for Melissa Epperly

Key filing fact

Melissa B. Epperly filed Form 4 for Roivant Sciences Ltd. (ROIV) on 06 Jul 2023.

Key facts

This page summarizes Melissa B. Epperly's Form 4 filing for Roivant Sciences Ltd. (ROIV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Jul 2023, 21:30.

Change

Previous filing in this sequence was filed on 16 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ROIV transaction

Common Shares

Award

Transaction value: $0
Shares: +1,280
Change %
Price: $0.000000
Shares after: 1,280
Date: 03 Jul 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date.